Patent · US Expired

Quinazolines, pharmaceutical compositions containing these compounds, their use and processes for preparing them

US6403580B1 · kind B1 · utility

41Cited by
1References
8Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 23, 2001
Grant dateJun 11, 2002
Priority date
Expiry dateAug 23, 2021

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D413/12
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Quinazolines of the formula having an inhibitory effect on signal transduction mediated by tyrosine kinases, the use thereof for treating diseases, particularly tumoral diseases, diseases of the lungs and respiratory tract, and the preparation thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.